Estimating Probabilities of Success of Vaccine and Other Anti-Infective Therapeutic Development Programs
A key driver in biopharmaceutical investment decisions is the probability of success of a drug development program. We estimate the probabilities of success (PoSs) of clinical trials for vaccines and other anti-infective therapeutics using 43,414 unique triplets of clinical trial, drug, and disease...
Main Authors: | Lo, Andrew W, Siah, Kien Wei, Wong, Chi Heem |
---|---|
Other Authors: | Sloan School of Management |
Format: | Article |
Language: | English |
Published: |
MIT Press
2021
|
Online Access: | https://hdl.handle.net/1721.1/129805 |
Similar Items
-
Estimation of clinical trial success rates and related parameters
by: Wong, Chi Heem, et al.
Published: (2020) -
Estimation of clinical trial success rates and related parameters
by: Wong, Chi Heem
Published: (2018) -
Should we allocate more COVID-19 vaccine doses to non-vaccinated individuals?
by: Ben Chaouch, Zied, et al.
Published: (2022) -
Issue 1 (Machine Learning with Statistical Imputation for Predicting Drug Approval)
by: Lo, Andrew W, et al.
Published: (2021) -
A cost/benefit analysis of clinical trial designs for COVID-19 vaccine candidates
by: Berry, Donald A., et al.
Published: (2021)